Key result
Delphi panel agrees on childhood cancer survivor stroke management but asymptomatic MRI screening consensus reaches ~67%.
Why the study?
Evidence is not available to guide management of childhood cancer survivors at risk for radiation-associated cerebral vascular disease and stroke.
A Delphi panel established expert consensus on several aspects of managing stroke risk in childhood cancer survivors treated with cranial radiation, highlighting areas of controversy such as surveillance imaging and aspirin use.
Answers are grounded in this paper and cite their sources.
May guide stroke prevention in childhood cancer survivors; leaves open routine MRI screening pending higher-level evidence.
BACKGROUND: Evidence is not available to guide management of childhood cancer survivors (CCS) at risk for radiation-associated cerebral vascular disease (CVD) and stroke. We propose to use a consensus-based methodology to describe the collective opinion of regional experts for the care of these patients and identify areas of controversy. PROCEDURE: Thirty physicians from the New England region who care for CCS participated in a Delphi panel querying their management approach (imaging, laboratory tests, medications, counseling, referrals) to a CCS treated with cranial radiation formatted as five clinical scenarios (asymptomatic, small- and large-vessel CVD, transient ischemia, stroke) in three rounds of anonymous questionnaires. Consensus defined as ≥90% agreement. RESULTS: Response rate was 100% for all three rounds. Panelists reached consensus on laboratory tests to assess stroke risk factors, stroke risk and prevention counseling, brain imaging to monitor survivors with known CVD, and acute care for stroke symptoms. Only 67% panelists agreed with MRI screening asymptomatic survivors with no history of CVD, 87% endorsed aspirin as stroke prevention for large-vessel CVD and 57% for small-vessel CVD. There was no consensus on specialty referrals. Overall, panelists practicing at large institutions and neurology subspecialists were more likely to advocate for screening, interventions, and referrals. CONCLUSIONS: Despite lack of evidence to guide stroke prevention in CCS treated with cranial radiation, a panel of regional physicians reached consensus on managing most clinical scenarios. Controversial areas requiring further study are surveillance imaging for asymptomatic survivors, aspirin for stroke prevention, and indications for specialty referral.
No takes yet. Share an insight, caveat, or question.
Kenney et al. (2018) studied Childhood cancer survivors at risk for stroke (n=30). Delphi survey on management approaches was evaluated on Consensus (≥90% agreement) on management approaches. A Delphi panel of 30 physicians reached consensus on stroke risk management in childhood cancer survivors, but lacked consensus on MRI screening for asymptomatic survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: